ARK Investment Management LLC Has $301,000 Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

ARK Investment Management LLC grew its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 128.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,179 shares of the company’s stock after acquiring an additional 5,155 shares during the period. ARK Investment Management LLC’s holdings in ARK Genomic Revolution ETF were worth $301,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Envestnet Portfolio Solutions Inc. acquired a new stake in ARK Genomic Revolution ETF during the third quarter worth approximately $274,000. BKM Wealth Management LLC acquired a new stake in ARK Genomic Revolution ETF during the fourth quarter worth approximately $78,000. Banque Pictet & Cie SA acquired a new stake in ARK Genomic Revolution ETF during the third quarter worth approximately $264,000. Sweet Financial Partners LLC acquired a new stake in ARK Genomic Revolution ETF during the fourth quarter worth approximately $525,000. Finally, Bellecapital International Ltd. lifted its position in ARK Genomic Revolution ETF by 1.5% during the third quarter. Bellecapital International Ltd. now owns 73,531 shares of the company’s stock worth $2,049,000 after acquiring an additional 1,084 shares during the last quarter.

ARK Genomic Revolution ETF Price Performance

Shares of ARKG stock opened at $28.56 on Thursday. The stock’s 50-day moving average is $29.86 and its 200 day moving average is $28.76.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.